Serological assays for emerging coronaviruses: Challenges and pitfalls

Virus Research

Volumn 194, Issue , 2014, Pages 175-183

  Meyer, Benjamin ^a   Drosten, Christian ^a   Müller, Marcel A ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Antibody; Cross reactivity; MERS Coronavirus; Reservoir; SARS Coronavirus; Serology

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; NUCLEOCAPSID PROTEIN; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CORONAVIRUS; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HUMAN; IMMUNOFLUORESCENCE TEST; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; SARS CORONAVIRUS; SERODIAGNOSIS; SEROLOGY; VIRUS NEUTRALIZATION; WESTERN BLOTTING; ANIMAL; BLOOD; CORONAVIRIDAE; CORONAVIRIDAE INFECTIONS; DIAGNOSTIC TEST; IMMUNOLOGY; PROCEDURES; VETERINARY;

ANIMALIA; CORONAVIRUS; SARS CORONAVIRUS;

ANIMALS; ANTIBODIES, VIRAL; CORONAVIRIDAE INFECTIONS; CORONAVIRUS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; SEROLOGIC TESTS;

EID: 84920655857     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.03.018     Document Type: Article

References (96)

1. Aburizaiza A.S., Mattes F.M., Azhar E.I., Hassan A.M., Memish Z.A., Muth D., Meyer B., Lattwein E., Muller M.A., Drosten C. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. The Journal of infectious diseases 2014, 209(2):243-246.
2. Annan A., Baldwin H.J., Corman V.M., Klose S.M., Owusu M., Nkrumah E.E., Badu E.K., Anti P., Agbenyega O., Meyer B., Oppong S., Sarkodie Y.A., Kalko E.K., Lina P.H., Godlevska E.V., Reusken C., Seebens A., Gloza-Rausch F., Vallo P., Tschapka M., Drosten C., Drexler J.F. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg. Infect. Dis. 2013, 19(3):456-459.
3. Anthony S.J., Ojeda-Flores R., Rico-Chavez O., Navarrete-Macias I., Zambrana-Torrelio C.M., Rostal M.K., Epstein J.H., Tipps T., Liang E., Sanchez-Leon M., Sotomayor-Bonilla J., Aguirre A.A., Avila-Flores R., Medellin R.A., Goldstein T., Suzan G., Daszak P., Lipkin W.I. Coronaviruses in bats from Mexico. J. Gen. Virol. 2013, 94(Pt 5):1028-1038.
4. Bermingham A., Chand M.A., Brown C.S., Aarons E., Tong C., Langrish C., Hoschler K., Brown K., Galiano M., Myers R., Pebody R.G., Green H.K., Boddington N.L., Gopal R., Price N., Newsholme W., Drosten C., Fouchier R.A., Zambon M. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro surveillance: bulletin Europeen sur les maladies transmissibles 2012, 17(40):20290.
5. Bradburne A.F. Antigenic relationships amongst coronaviruses. Arch. Gesamte Virusforsch. 1970, 31(3):352-364.
6. Buchholz U., Muller M.A., Nitsche A., Sanewski A., Wevering N., Bauer-Balci T., Bonin F., Drosten C., Schweiger B., Wolff T., Muth D., Meyer B., Buda S., Krause G., Schaade L., Haas W. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro surveillance: bulletin Europeen sur les maladies transmissibles 2013, 18(8). pii: 20406.
7. Buchholz U.J., Bukreyev A., Yang L., Lamirande E.W., Murphy B.R., Subbarao K., Collins P.L. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(26):9804-9809.
8. Burbelo P.D., Dubovi E.J., Simmonds P., Medina J.L., Henriquez J.A., Mishra N., Wagner J., Tokarz R., Cullen J.M., Iadarola M.J., Rice C.M., Lipkin W.I., Kapoor A. Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J. Virol. 2012, 86(11):6171-6178.
9. Carattoli A., Di Bonito P., Grasso F., Giorgi C., Blasi F., Niedrig M., Cassone A. Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosis of SARS. J. Med. Virol. 2005, 76(2):137-142.
10. Chan-Yeung M., Xu R.H. SARS: epidemiology. Respirology 2003, 8:S9-S14.
11. Chan C.M., Tse H., Wong S.S., Woo P.C., Lau S.K., Chen L., Zheng B.J., Huang J.D., Yuen K.Y. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol. 2009, 45(1):54-60.
12. Chan K.H., Chan J.F., Tse H., Chen H., Lau C.C., Cai J.P., Tsang A.K., Xiao X., To K.K., Lau S.K., Woo P.C., Zheng B.J., Wang M., Yuen K.Y. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J. Infect. 2013, 67(2):130-140.
13. Chan K.H., Poon L.L., Cheng V.C., Guan Y., Hung I.F., Kong J., Yam L.Y., Seto W.H., Yuen K.Y., Peiris J.S. Detection of SARS coronavirus in patients with suspected SARS. Emerg. Infect. Dis. 2004, 10(2):294-299.
14. Chan P.K., Ng K.C., Chan R.C., Lam R.K., Chow V.C., Hui M., Wu A., Lee N., Yap F.H., Cheng F.W., Sung J.J., Tam J.S. Immunofluorescence assay for serologic diagnosis of SARS. Emerg. Infect. Dis. 2004, 10(3):530-532.
15. Che X.Y., Qiu L.W., Liao Z.Y., Wang Y.D., Wen K., Pan Y.X., Hao W., Mei Y.B., Cheng V.C., Yuen K.Y. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J. Infect. Dis. 2005, 191(12):2033-2037.
16. Chen X., Zhou B., Li M., Liang X., Wang H., Yang G., Le X. Serology of severe acute respiratory syndrome: implications for surveillance and outcome. J. Infect. Dis. 2004, 189(7):1158-1163.
17. Chen Z., Pei D., Jiang L., Song Y., Wang J., Wang H., Zhou D., Zhai J., Du Z., Li B., Qiu M., Han Y., Guo Z., Yang R. Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin. Chem. 2004, 50(6):988-995.
18. Corman V., Eckerle I., Bleicker T., Zaki A., Landt O., Eschbach-Bludau M., van Boheemen S., Gopal R., Ballhause M., Bestebroer T., Muth D., Muller M., Drexler J., Zambon M., Osterhaus A., Fouchier R., Drosten C. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro surveillance: bulletin Europeen sur les maladies transmissibles 2012, 17(39). pii: 20285.
19. Corman V.M., Muller M.A., Costabel U., Timm J., Binger T., Meyer B., Kreher P., Lattwein E., Eschbach-Bludau M., Nitsche A., Bleicker T., Landt O., Schweiger B., Drexler J.F., Osterhaus A.D., Haagmans B.L., Dittmer U., Bonin F., Wolff T., Drosten C. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro surveillance: bulletin Europeen sur les maladies transmissibles 2012, 17(49). pii: 20334.
20. Dijkman R., Jebbink M.F., Gaunt E., Rossen J.W., Templeton K.E., Kuijpers T.W., van der Hoek L. The dominance of human coronavirus OC43 and NL63 infections in infants. J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol. 2012, 53(2):135-139.
21. Drexler J.F., Corman V.M., Muller M.A., Lukashev A.N., Gmyl A., Coutard B., Adam A., Ritz D., Leijten L.M., van Riel D., Kallies R., Klose S.M., Gloza-Rausch F., Binger T., Annan A., Adu-Sarkodie Y., Oppong S., Bourgarel M., Rupp D., Hoffmann B., Schlegel M., Kummerer B.M., Kruger D.H., Schmidt-Chanasit J., Setien A.A., Cottontail V.M., Hemachudha T., Wacharapluesadee S., Osterrieder K., Bartenschlager R., Matthee S., Beer M., Kuiken T., Reusken C., Leroy E.M., Ulrich R.G., Drosten C. Evidence for novel hepaciviruses in rodents. PLoS Pathog. 2013, 9(6):e1003438.
22. Drexler J.F., Corman V.M., Muller M.A., Maganga G.D., Vallo P., Binger T., Gloza-Rausch F., Rasche A., Yordanov S., Seebens A., Oppong S., Sarkodie Y.A., Pongombo C., Lukashev A.N., Schmidt-Chanasit J., Stocker A., Carneiro A.J., Erbar S., Maisner A., Fronhoffs F., Buettner R., Kalko E.K., Kruppa T., Franke C.R., Kallies R., Yandoko E.R., Herrler G., Reusken C., Hassanin A., Kruger D.H., Matthee S., Ulrich R.G., Leroy E.M., Drosten C. Bats host major mammalian paramyxoviruses. Nature Commun. 2012, 3:796.
23. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New Engl. J. Med. 2003, 348(20):1967-1976.
24. Drosten C., Seilmaier M., Corman V.M., Hartmann W., Scheible G., Sack S., Guggemos W., Kallies R., Muth D., Junglen S., Muller M.A., Haas W., Guberina H., Rohnisch T., Schmid-Wendtner M., Aldabbagh S., Dittmer U., Gold H., Graf P., Bonin F., Rambaut A., Wendtner C.M. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 2013, 13(9):745-751.
25. Ecker B., Vollenhofer S., Bares T., Schalkhammer T., Schinkinger M., Pittner F. Overexpression and purification of a recombinant chimeric HIV type 2/HIV type 1 envelope peptide and application in an accelerated immunobased HIV type 1/2 antibody detection system (AIBS): a new rapid serological screening assay. AIDS Res. Hum. Retrovir. 1996, 12(12):1081-1091.
26. Farber I., Wutzler P., Wohlrabe P., Wolf H., Hinderer W., Sonneborn H.H. Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs. J. Virol. Methods 1993, 42(2-3):301-307.
27. Fukushi S., Watanabe R., Taguchi F. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins. Methods Mol. Biol. 2008, 454:331-338.
28. Ge X.Y., Li J.L., Yang X.L., Chmura A.A., Zhu G., Epstein J.H., Mazet J.K., Hu B., Zhang W., Peng C., Zhang Y.J., Luo C.M., Tan B., Wang N., Zhu Y., Crameri G., Zhang S.Y., Wang L.F., Daszak P., Shi Z.L. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013, 503(7477):535-538.
29. Gerna G., Cereda P.M., Revello M.G., Cattaneo E., Battaglia M., Gerna M.T. Antigenic and biological relationships between human coronavirus Oc43 and neonatal calf diarrhea coronavirus. J. Gen. Virol. 1981, 54(May):91-102.
30. Gierer S., Bertram S., Kaup F., Wrensch F., Heurich A., Kramer-Kuhl A., Welsch K., Winkler M., Meyer B., Drosten C., Dittmer U., von Hahn T., Simmons G., Hofmann H., Pohlmann S. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J. Virol. 2013, 87(10):5502-5511.
31. Gierer S., Hofmann-Winkler H., Albuali W.H., Bertram S., Al-Rubaish A.M., Yousef A.A., Al-Nafaie A.N., Al-Ali A.K., Obeid O.E., Alkharsah K.R., Pohlmann S. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia. Emerg. Infect. Dis. 2013, 19(12):2034-2036.
32. Gorse G.J., Patel G.B., Vitale J.N., O'Connor T.Z. Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum. Clin. Vaccine Immunol. 2010, 17(12):1875-1880.
33. Grundner C., Pancera M., Kang J.M., Koch M., Sodroski J., Wyatt R. Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins. Virology 2004, 330(1):233-248.
34. Guan M., Chan K.H., Peiris J.S., Kwan S.W., Lam S.Y., Pang C.M., Chu K.W., Chan K.M., Chen H.Y., Phuah E.B., Wong C.J. Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome. Clin. Diagn. Lab. Immunol. 2004, 11(4):699-703.
35. Guan M., Chen H.Y., Foo S.Y., Tan Y.J., Goh P.Y., Wee S.H. Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients. Clin. Diagn. Lab. Immunol. 2004, 11(2):287-291.
36. Guan M., Chen H.Y., Tan P.H., Shen S., Goh P.Y., Tan Y.J., Pang P.H., Lu Y., Fong P.Y., Chin D. Use of viral lysate antigen combined with recombinant protein in Western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome. Clin. Diagn. Lab. Immunol. 2004, 11(6):1148-1153.
37. Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W., Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W., Shortridge K.F., Yuen K.Y., Peiris J.S., Poon L.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003, 302(5643):276-278.
38. Guery B., Poissy J.,Mansouf L., Sejourne C., Ettahar N., Lemaire X., Vuotto F., Goffard A., Behillil S., Enouf V., Caro V., Mailles A., Che D., Manuguerra J.C., Mathieu D., Fontanet A., van der Werf S. Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet 2013, 381(9885):2265-2272.
39. Haagmans B.L., Al Dhahiry S.H., Reusken C.B., Raj V.S., Galiano M., Myers R., Godeke G.J., Jonges M., Farag E., Diab A., Ghobashy H., Alhajri F., Al-Thani M., Al-Marri S.A., Al Romaihi H.E., Al Khal A., Bermingham A., Osterhaus A.D., Alhajri M.M., Koopmans M.P. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 2013, 14(2):140-145.
40. He Q., Chong K.H., Chng H.H., Leung B., Ling A.E., Wei T., Chan S.W., Ooi E.E., Kwang J. Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome. Clin. Diagn. Lab. Immunol. 2004, 11(2):417-422.
41. He Y., Zhou Y., Wu H., Luo B., Chen J., Li W., Jiang S. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J. Immunol. 2004, 173(6):4050-4057.
42. Hofmann H., Hattermann K., Marzi A., Gramberg T., Geier M., Krumbiegel M., Kuate S., Uberla K., Niedrig M., Pohlmann S. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J. Virol. 2004, 78(12):6134-6142.
43. Hofmann H., Pyrc K., van der Hoek L., Geier M., Berkhout B., Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(22):7988-7993.
44. Horzinek M.C., Lutz H., Pedersen N.C. Antigenic relationships among homologous structural polypeptides of porcine, feline, and canine coronaviruses. Infect. Immun. 1982, 37(3):1148-1155.
45. Hpa H.P.A. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles 2013, 18(11):20427.
46. Hsueh P.R., Hsiao C.H., Yeh S.H., Wang W.K., Chen P.J., Wang J.T., Chang S.C., Kao C.L., Yang P.C. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg. Infect. Dis. 2003, 9(9):1163-1167.
47. Isaacs D., Flowers D., Clarke J.R., Valman H.B., MacNaughton M.R. Epidemiology of coronavirus respiratory infections. Arch. Dis. Child. 1983, 58(7):500-503.
48. Ithete N.L., Stoffberg S., Corman V.M., Cottontail V.M., Richards L.R., Schoeman M.C., Drosten C., Drexler J.F., Preiser W. Close relative of human middle East respiratory syndrome coronavirus in bat, South Africa. Emerg. Infect. Dis. 2013, 19(10):1697-1699.
49. Kan B., Wang M., Jing H., Xu H., Jiang X., Yan M., Liang W., Zheng H., Wan K., Liu Q., Cui B., Xu Y., Zhang E., Wang H., Ye J., Li G., Li M., Cui Z., Qi X., Chen K., Du L., Gao K., Zhao Y.T., Zou X.Z., Feng Y.J., Gao Y.F., Hai R., Yu D., Guan Y., Xu J. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J. Virol. 2005, 79(18):11892-11900.
50. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J. A novel coronavirus associated with severe acute respiratory syndrome. New Engl. J. Med. 2003, 348(20):1953-1966.
51. Larson H.E., Reed S.E., Tyrrell D.A. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. Med. Virol. 1980, 5(3):221-229.
52. Lau S.K., Woo P.C., Li K.S., Huang Y., Tsoi H.W., Wong B.H., Wong S.S., Leung S.Y., Chan K.H., Yuen K.Y. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(39):14040-14045.
53. Leung D.T., Tam F.C., Ma C.H., Chan P.K., Cheung J.L., Niu H., Tam J.S., Lim P.L. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J. Infect. Dis. 2004, 190(2):379-386.
54. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., Zhang J., McEachern J., Field H., Daszak P., Eaton B.T., Zhang S., Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005, 310(5748):676-679.
55. Liu X., Shi Y., Li P., Li L., Yi Y., Ma Q., Cao C. Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clin. Diagn. Lab. Immunol. 2004, 11(1):227-228.
56. Maache M., Komurian-Pradel F., Rajoharison A., Perret M., Berland J.L., Pouzol S., Bagnaud A., Duverger B., Xu J., Osuna A., Paranhos-Baccala G. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV. Clin. Vaccine Immunol. 2006, 13(3):409-414.
57. Manopo I., Lu L., He Q., Chee L.L., Chan S.W., Kwang J. Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV. J. Immunol. Methods 2005, 296(1-2):37-44.
58. McIntosh K., Kapikian A.Z., Hardison K.A., Hartley J.W., Chanock R.M. Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J. Immunol. 1969, 102(5):1109-1118.
59. Memish Z.A., Mishra N., Olival K.J., Fagbo S.F., Kapoor V., Epstein J.H., Alhakeem R., Durosinloun A., Al Asmari M., Islam A., Kapoor A., Briese T., Daszak P., Al Rabeeah A.A., Lipkin W.I. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis. 2013, 19(11).
60. Meyer B., Muller M.A., Corman V.M., Reusken C.B., Ritz D., Godeke G.J., Lattwein E., Kallies S., Siemens A., van Beek J., Drexler J.F., Muth D., Bosch B.J., Wernery U., Koopmans M.P., Wernery R., Drosten C. Antibodies against MERS Coronavirus in Dromedary Camels. United Arab Emirates, 2003 and 2013. Emerging infectious diseases 2014, 20(4):552-559.
61. Monto A.S. Medical reviews. Coronaviruses. Yale J. Biol. Med. 1974, 47(4):234-251.
62. Muller M.A., Paweska J.T., Leman P.A., Drosten C., Grywna K., Kemp A., Braack L., Sonnenberg K., Niedrig M., Swanepoel R. Coronavirus antibodies in African bat species. Emerg. Infect. Dis. 2007, 13(9):1367-1370.
63. Murphy K., Travers P., Walport M. The Distribution and Functions of Immunoglobulin Classes. Janeway's Immunobiology 2008, 400-401. Garland Science, New York. 7th ed.
64. Narayanan K., Huang C., Makino S. SARS coronavirus accessory proteins. Virus Res. 2008, 133(1):113-121.
65. Neuman B.W., Joseph J.S., Saikatendu K.S., Serrano P., Chatterjee A., Johnson M.A., Liao L., Klaus J.P., Yates J.R., Wuthrich K., Stevens R.C., Buchmeier M.J., Kuhn P. Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. J. Virol. 2008, 82(11):5279-5294.
66. Niedrig M., Leitmeyer K., Lim W., Peiris M., Mackenzie J.S., Zambon M. First external quality assurance of antibody diagnostic for SARS-new coronavirus. J. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol. 2005, 34(1):22-25.
67. Patrick D.M., Petric M., Skowronski D.M., Guasparini R., Booth T.F., Krajden M., McGeer P., Bastien N., Gustafson L., Dubord J., Macdonald D., David S.T., Srour L.F., Parker R., Andonov A., Isaac-Renton J., Loewen N., McNabb G., McNabb A., Goh S.H., Henwick S., Astell C., Guo J.P., Drebot M., Tellier R., Plummer F., Brunham R.C. An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus. Journal canadien des maladies infectieuses et de la microbiologie medicale/AMMI Canada 2006, 17(6):330-336.
68. Peel A.J., McKinley T.J., Baker K.S., Barr J.A., Crameri G., Hayman D.T., Feng Y.R., Broder C.C., Wang L.F., Cunningham A.A., Wood J.L. Use of cross-reactive serological assays for detecting novel pathogens in wildlife: assessing an appropriate cutoff for henipavirus assays in African bats. J. Virol. Methods 2013, 193(2):295-303.
69. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., Yuen K.Y. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361(9366):1319-1325.
70. Perera R., Wang P., Gomaa M., El-Shesheny R., Kandeil A., Bagato O., Siu L., Shehata M., Kayed A., Moatasim Y., Li M., Poon L., Guan Y., Webby R., Ali M., Peiris J., Kayali G. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles 2013, 18(36). pii=20574.
71. Pfefferle S., Oppong S., Drexler J.F., Gloza-Rausch F., Ipsen A., Seebens A., Muller M.A., Annan A., Vallo P., Adu-Sarkodie Y., Kruppa T.F., Drosten C. Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg. Infect. Dis. 2009, 15(9):1377-1384.
72. Poon L.L., Chu D.K., Chan K.H., Wong O.K., Ellis T.M., Leung Y.H., Lau S.K., Woo P.C., Suen K.Y., Yuen K.Y., Guan Y., Peiris J.S. Identification of a novel coronavirus in bats. J. Virol. 2005, 79(4):2001-2009.
73. Puzelli S., Azzi A., Santini M.G., Di Martino A., Facchini M., Castrucci M.R., Meola M., Arvia R., Corcioli F., Pierucci F., Baretti S., Bartoloni A., Bartolozzi D., de Martino M., Galli L., Pompa M.G., Rezza G., Balocchini E., Donatelli I. Investigation of an imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles 2013, 18(34). pii: 20564.
74. Qiu M., Shi Y., Guo Z., Chen Z., He R., Chen R., Zhou D., Dai E., Wang X., Si B., Song Y., Li J., Yang L., Wang J., Wang H., Pang X., Zhai J., Du Z., Liu Y., Zhang Y., Li L., Sun B., Yang R. Antibody responses to individual proteins of SARS coronavirus and their neutralization activities. Microbes Infect./Institut Pasteur 2005, 7(5-6):882-889.
75. Quan P.L., Firth C., Street C., Henriquez J.A., Petrosov A., Tashmukhamedova A., Hutchison S.K., Egholm M., Osinubi M.O., Niezgoda M., Ogunkoya A.B., Briese T., Rupprecht C.E., Lipkin W.I. Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria. mBio 2010, 1(4). pii: e00208-10.
76. Reusken C., Mou H., Godeke G.J., van der Hoek L., Meyer B., Muller M.A., Haagmans B., de Sousa R., Schuurman N., Dittmer U., Rottier P., Osterhaus A., Drosten C., Bosch B.J., Koopmans M. Specific serology for emerging human coronaviruses by protein microarray. Euro surveillance: bulletin Europeen sur les maladies transmissibles 2013, 18(14):20441.
77. Reusken C.B., Haagmans B.L., Muller M.A., Gutierrez C., Godeke G.J., Meyer B., Muth D., Raj V.S., Vries L.S., Corman V.M., Drexler J.F., Smits S.L., El Tahir Y.E., De Sousa R., van Beek J., Nowotny N., van Maanen K., Hidalgo-Hermoso E., Bosch B.J., Rottier P., Osterhaus A., Gortazar-Schmidt C., Drosten C., Koopmans M.P. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 2013, 13(10):859-866.
78. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.H., Tong S., Tamin A., Lowe L., Frace M., DeRisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300(5624):1394-1399.
79. Schaecher S.R., Mackenzie J.M., Pekosz A. The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J. Virol. 2007, 81(2):718-731.
80. Shi Y., Yi Y., Li P., Kuang T., Li L., Dong M., Ma Q., Cao C. Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J. Clin. Microbiol. 2003, 41(12):5781-5782.
81. Tam J.S. Influenza A (H5N1) in Hong Kong: an overview. Vaccine 2002, 20(Suppl. 2):S77L 81.
82. Tan Y.J., Goh P.Y., Fielding B.C., Shen S., Chou C.F., Fu J.L., Leong H.N., Leo Y.S., Ooi E.E., Ling A.E., Lim S.G., Hong W. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin. Diagn. Lab. Immunol. 2004, 11(2):362-371.
83. Tu C., Crameri G., Kong X., Chen J., Sun Y., Yu M., Xiang H., Xia X., Liu S., Ren T., Yu Y., Eaton B.T., Xuan H., Wang L.F. Antibodies to SARS coronavirus in civets. Emerg. Infect. Dis. 2004, 10(12):2244-2248.
84. Wang Y., Chang Z., Ouyang J., Wei H., Yang R., Chao Y., Qu J., Wang J., Hung T. Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients. DNA Cell Biol. 2005, 24(8):521-527.
85. Wang Y.D., Li Y., Xu G.B., Dong X.Y., Yang X.A., Feng Z.R., Tian C., Chen W.F. Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot. Clin. Immunol. 2004, 113(2):145-150.
86. Watts J. China culls wild animals to prevent new SARS threat. Lancet 2004, 363(9403):134.
87. WHO WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS) 2004, vol. 2013.
88. WHO Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - update 2014.
89. Woo P.C., Lau S.K., Tsoi H.W., Chan K.H., Wong B.H., Che X.Y., Tam V.K., Tam S.C., Cheng V.C., Hung I.F., Wong S.S., Zheng B.J., Guan Y., Yuen K.Y. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 2004, 363(9412):841-845.
90. Woo P.C., Lau S.K., Wong B.H., Chan K.H., Chu C.M., Tsoi H.W., Huang Y., Peiris J.S., Yuen K.Y. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin. Diagn. Lab. Immunol. 2004, 11(4):665-668.
91. Woo P.C., Lau S.K., Wong B.H., Chan K.H., Hui W.T., Kwan G.S., Peiris J.S., Couch R.B., Yuen K.Y. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J. Clin. Microbiol. 2004, 42(12):5885-5888.
92. Woo P.C., Lau S.K., Wong B.H., Tsoi H.W., Fung A.M., Kao R.Y., Chan K.H., Peiris J.S., Yuen K.Y. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J. Clin. Microbiol. 2005, 43(7):3054-3058.
93. Wu H.S., Chiu S.C., Tseng T.C., Lin S.F., Lin J.H., Hsu Y.H., Wang M.C., Lin T.L., Yang W.Z., Ferng T.L., Huang K.H., Hsu L.C., Lee L.L., Yang J.Y., Chen H.Y., Su S.P., Yang S.Y., Lin S.Y., Lin T.H., Su I.S. Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. Emerg. Infect. Dis. 2004, 10(2):304-310.
94. Yam W.C., Chan K.H., Poon L.L., Guan Y., Yuen K.Y., Seto W.H., Peiris J.S. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. J. Clin. Microbiol. 2003, 41(10):4521-4524.
95. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New Engl. J. Med. 2012, 367(19):1814-1820.
96. Zhong N.S., Zheng B.J., Li Y.M., Poon Xie Z.H., Chan K.H., Li P.H., Tan S.Y., Chang Q., Xie J.P., Liu X.Q., Xu J., Li D.X., Yuen K.Y., Peiris Guan Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 2003, 362(9393):1353-1358.